Synergy between chemotherapy and cancer vaccination.

PubWeight™: 0.76^‹?›

🔗 View Article (PMC 4505152)

Published in Aging (Albany NY) on June 01, 2015

Authors

Tetje C van der Sluis¹, Sjoerd H van der Burg², Cornelis J Melief¹^,3

Author Affiliations

1: Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre (LUMC), the Netherlands.
2: Department of Clinical Oncology, Leiden University Medical Centre (LUMC), the Netherlands.
3: ISA Pharmaceuticals, Leiden, the Netherlands.

Articles citing this ↘

Combination Approaches with Immune-Checkpoint Blockade in Cancer Therapy. Front Oncol (2016) 0.77

Articles cited by this ↗

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature (2014) 5.34

Neoantigens in cancer immunotherapy. Science (2015) 5.16

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61

Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells. Kidney Int (2007) 2.45

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines. Nat Rev Cancer (2008) 2.31

Efficiency of recombinant human TNF in human cancer therapy. Cancer Immun (2006) 1.58

Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death. Clin Cancer Res (2014) 0.95